-+ 0.00%
-+ 0.00%
-+ 0.00%

Helus Pharma Q1 EPS $(0.91) Beats $(1.07) Estimate

Benzinga·08/14/2026 11:53:27
Listen to the news
Helus Pharma (NASDAQ:HELP) reported quarterly losses of $(0.91) per share which beat the analyst consensus estimate of $(1.07) by 14.95 percent. This is a 17.27 percent increase over losses of $(1.10) per share from the same period last year.